Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuben Granich

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Epidemiology|April 13, 2007
Commentary: back to basics--good news from a birthplace of DOTSReuben Granich
The Lancet. Infectious Diseases|February 5, 2013
HIV in MSM in England and Wales: back to the drawing board?Reuben Granich
Lancet (London, England)|November 6, 2018
Is the global tuberculosis control strategy too big to fail?Reuben Granich
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2008
HIV and MDR-TB in Ukraine: news from a hazardous MDR-TB and HIV siteReuben Granich
The Lancet. Global Health|April 5, 2026
The lenacapavir paradox: why a promising prevention tool raises difficult questions about African HIV response prioritiesReuben Granich
Journal of the International Association of Providers of AIDS Care|January 17, 2017
National HIV Care Continua for Key PopulationsSomya Gupta, Reuben Granich
Southern African Journal of HIV Medicine|March 24, 2018
When will sub-Saharan Africa adopt HIV treatment for all?Somya Gupta, Reuben Granich
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 2, 2021
European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV PandemicReuben Granich, Somya Gupta
Lancet (London, England)|January 15, 2016
HIV treatment: time to lean forwardReuben Granich, Brian Williams
The Lancet. Infectious Diseases|April 23, 2013
Economics of monitoring antiretroviral therapyJonathan Mermin, Reuben Granich
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Epidemiology|April 13, 2007
Commentary: back to basics--good news from a birthplace of DOTSReuben Granich
The Lancet. Infectious Diseases|February 5, 2013
HIV in MSM in England and Wales: back to the drawing board?Reuben Granich
Lancet (London, England)|November 6, 2018
Is the global tuberculosis control strategy too big to fail?Reuben Granich
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2008
HIV and MDR-TB in Ukraine: news from a hazardous MDR-TB and HIV siteReuben Granich
The Lancet. Global Health|April 5, 2026
The lenacapavir paradox: why a promising prevention tool raises difficult questions about African HIV response prioritiesReuben Granich
Journal of the International Association of Providers of AIDS Care|January 17, 2017
National HIV Care Continua for Key PopulationsSomya Gupta, Reuben Granich
Southern African Journal of HIV Medicine|March 24, 2018
When will sub-Saharan Africa adopt HIV treatment for all?Somya Gupta, Reuben Granich
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 2, 2021
European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV PandemicReuben Granich, Somya Gupta
Lancet (London, England)|January 15, 2016
HIV treatment: time to lean forwardReuben Granich, Brian Williams
The Lancet. Infectious Diseases|April 23, 2013
Economics of monitoring antiretroviral therapyJonathan Mermin, Reuben Granich
Pageof 8